연구성과로 돌아가기

2024 연구성과별 연구자 정보 (725 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Effects of ultrasonic nanocrystal surface modification treatment and subsequent annealing on the microstructure and mechanical properties of rolled AZ31 alloy Park, Sung Hyuk Park, SH 5 교신저자 Kyungpook Natl Univ, Grad Sch Mat Sci & Engn, Daegu 41566, South Korea sh.park@knu.ac.kr;
Effects of wheat flour levels on the thermal curing behavior of Urea-Formaldehyde and Phenol-Formaldehyde resins Wibowo, Eko Setio Wibowo, ES 1 Kyungpook Natl Univ, Dept Wood & Paper Sci, Daegu 41566, South Korea AAL-5888-2021 Wibowo, Eko 0000-0001-5566-3408 Wibowo, Eko byungdae@knu.ac.kr;
Effects of wheat flour levels on the thermal curing behavior of Urea-Formaldehyde and Phenol-Formaldehyde resins Wibowo, Eko Setio Wibowo, ES 1 Natl Res & Innovat Agcy, Res Ctr Biomass & Bioprod, Bogor 16911, Indonesia AAL-5888-2021 Wibowo, Eko 0000-0001-5566-3408 Wibowo, Eko byungdae@knu.ac.kr;
Effects of wheat flour levels on the thermal curing behavior of Urea-Formaldehyde and Phenol-Formaldehyde resins Park, Byung-Dae Park, BD 2 교신저자 Kyungpook Natl Univ, Dept Wood & Paper Sci, Daegu 41566, South Korea ABB-1934-2020 Park, Byung-Dae 0000-0002-9802-7855 Park, Byung-Dae byungdae@knu.ac.kr;
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Weintraub, Y. Weintraub, Y 1 Schneider Childrens Med, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Weintraub, Y. Weintraub, Y 1 Tel Aviv Univ, Fac Med, Tel Aviv, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Veit, L. Collen Veit, LC 2 Boston Childrens Hosp, Boston, MA USA
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Veit, L. Collen Veit, LC 2 Harvard Med Sch, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Boston, MA USA
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Hussey, S. Hussey, S 3 Childrens Hlth Ireland UCD, Dublin, Ireland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Hussey, S. Hussey, S 3 RCSI Dublin Ireland, Pediat, Dublin, Ireland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Mitrova, K. Mitrova, K 4 Charles Univ Prague, Fac Med 2, Prague, Czech Republic
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Mitrova, K. Mitrova, K 4 Univ Hosp Motol, Dept Paediat, Prague, Czech Republic
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Mitrova, K. Mitrova, K 4 Charles Univ Prague, ISCARE, Prague, Czech Republic
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Mitrova, K. Mitrova, K 4 Charles Univ Prague, Fac Med 1, Clin & Res Ctr Inflammatory Bowel Dis, Prague, Czech Republic
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Croft, N. M. Croft, NM 5 Queen Mary Univ London, Fac Med, Blizard Inst, London, England
페이지 이동: